 Despite the application of IMRT and the studies of concurrent chemoradiation in esophageal carcinoma, which improves 5-year survival rate from 10 to 20-40 and decrease recurrence rate from 80 to 50-60, local recurrence remains to be the most common failure pattern. Therefore, enhancing local control is the key to obtain a better survival. 